StockNews.AI
BMY
Benzinga
137 days

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

1. BMY has a dividend yield of 4.29%. Recent analysts raised price targets for BMY. 2. Wells Fargo raised BMY price target from $60 to $62, maintaining Equal-Weight rating. 3. Citigroup also raised BMY price target from $60 to $65, maintaining Neutral rating. 4. BMY received positive CHMP opinion for subcutaneous Opdiv formulation across solid tumors. 5. High dividend yields attract investors during market uncertainty.

4m saved
Insight
Article

FAQ

Why Bullish?

The rise in price targets from analysts indicates positive sentiment towards BMY's future growth potential. Historical data shows that analyst upgrades can lead to stock price increases.

How important is it?

The combination of a solid dividend yield, analyst upgrades, and positive regulatory news suggests a strong influence on price movement. These factors are critical for investors focusing on BMY.

Why Short Term?

The positive CHMP opinion and analyst upgrades are likely to influence BMY's stock price soon as investor interest may surge. Similar past instances demonstrated immediate stock reactions following favorable news.

Related Companies

Related News